Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Murai

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
FEBS Letters|September 26, 2002
Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathyHirofumi Ochi, Izumi Horiuchi, Norie Araki, et al.
BMJ Open|July 21, 2021
Patient-reportedimpact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)Sonia Berrih-Aknin, Kristl G Claeys, Nancy Law, et al.
Therapeutic Advances in Neurological Disorders|April 13, 2023
Immunotherapy for ocular myasthenia gravis: an observational study in JapanTomoko Narita, Shunya Nakane, Akiko Nagaishi, et al.
Emerging Infectious Diseases|May 23, 2020
Characterization of Sporadic Creutzfeldt-Jakob Disease and History of Neurosurgery to Identify Potential Iatrogenic CasesTsuyoshi Hamaguchi, Kenji Sakai, Atsushi Kobayashi, et al.
BMJ Open|May 20, 2014
Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein geneTemu Qina, Nobuo Sanjo, Masaki Hizume, et al.
The Lancet. Neurology|June 19, 2021
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trialJames F Howard, Vera Bril, Tuan Vu, et al.
Annals of Clinical and Translational Neurology|October 20, 2015
Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathyHidenori Ogata, Ryo Yamasaki, Akio Hiwatashi, et al.
Annals of Neurology|August 23, 2015
Copy number variations in multiple sclerosis and neuromyelitis opticaShinya Sato, Ken Yamamoto, Takuya Matsushita, et al.
Neurology|November 4, 2020
International Consensus Guidance for Management of Myasthenia Gravis: 2020 UpdatePushpa Narayanaswami, Donald B Sanders, Gil Wolfe, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
FEBS Letters|September 26, 2002
Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathyHirofumi Ochi, Izumi Horiuchi, Norie Araki, et al.
BMJ Open|July 21, 2021
Patient-reportedimpact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)Sonia Berrih-Aknin, Kristl G Claeys, Nancy Law, et al.
Therapeutic Advances in Neurological Disorders|April 13, 2023
Immunotherapy for ocular myasthenia gravis: an observational study in JapanTomoko Narita, Shunya Nakane, Akiko Nagaishi, et al.
Emerging Infectious Diseases|May 23, 2020
Characterization of Sporadic Creutzfeldt-Jakob Disease and History of Neurosurgery to Identify Potential Iatrogenic CasesTsuyoshi Hamaguchi, Kenji Sakai, Atsushi Kobayashi, et al.
BMJ Open|May 20, 2014
Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein geneTemu Qina, Nobuo Sanjo, Masaki Hizume, et al.
The Lancet. Neurology|June 19, 2021
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trialJames F Howard, Vera Bril, Tuan Vu, et al.
Annals of Clinical and Translational Neurology|October 20, 2015
Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathyHidenori Ogata, Ryo Yamasaki, Akio Hiwatashi, et al.
Annals of Neurology|August 23, 2015
Copy number variations in multiple sclerosis and neuromyelitis opticaShinya Sato, Ken Yamamoto, Takuya Matsushita, et al.
Neurology|November 4, 2020
International Consensus Guidance for Management of Myasthenia Gravis: 2020 UpdatePushpa Narayanaswami, Donald B Sanders, Gil Wolfe, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
Pageof 17